Advanced Biomed Inc. (ADVB)
NASDAQ: ADVB · Real-Time Price · USD
2.980
-0.060 (-1.97%)
At close: Oct 28, 2026, 4:00 PM EDT
3.010
+0.030 (1.02%)
After-hours: Oct 28, 2026, 6:04 PM EDT

Advanced Biomed Financials Overview

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
0.130.13----
Revenue Growth
------
Gross Profit
0.130.13----
Operating Income
-6.23-6.23-1.09-2.54-3.07-2.37
Net Income
6.686.68-3.26-2.78-3.73-4.03
Earnings Per Share
5.335.33-3.18-2.78-3.74-5.68
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
0.390.390.032.612.624.78
Total Debt
1.081.08-0.910.240.47
Net Cash (Debt)
-0.69-0.690.031.72.394.31
Net Cash Growth
---98.17%-28.92%-44.68%7225.84%
Net Cash Per Share
-0.55-0.550.031.702.396.08

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-1.95-1.95-5.83-2.13-2.96-0.74
Capital Expenditures
----0.07-0.21-0.89
Free Cash Flow
-1.95-1.95-5.83-2.2-3.17-1.63
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
100.00%100.00%----
Operating Margin
-4883.81%-4883.81%----
Pretax Margin
-4906.48%-4906.48%----
Profit Margin
5231.30%5231.30%----
FCF Margin
-1525.38%-1525.38%----

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PE Ratio
0.561.15----
PS Ratio
37.9360.19----